The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The association between immune-related adverse events and efficacy outcomes with consolidation pembrolizumab after chemoradiation in patients with stage III NSCLC: an analysis from HCRN LUN 14-179.
 
Nikhil Shukla
Patents, Royalties, Other Intellectual Property - Combination of SapC-DOPS and AS1411 for the treatment of glioblastoma multiforme (Inst)
 
Sandra K. Althouse
No Relationships to Disclose
 
Ahad Ali Sadiq
Honoraria - Takeda; Takeda
Speakers' Bureau - Takeda
Travel, Accommodations, Expenses - Takeda
 
Shadia Ibrahim Jalal
Research Funding - Astex Pharmaceuticals; AstraZeneca/MedImmune; Tesaro
 
Salma K. Jabbour
Consulting or Advisory Role - Merck Sharp & Dohme
Research Funding - Merck Sharp & Dohme (Inst); Nestle health science (Inst)
Travel, Accommodations, Expenses - Merck Sharp & Dohme
 
Robin Zon
Stock and Other Ownership Interests - AC3
Consulting or Advisory Role - MedPro Specialty Advisory Board
 
Goetz H. Kloecker
No Relationships to Disclose
 
William B. Fisher
No Relationships to Disclose
 
Karen L. Reckamp
Consulting or Advisory Role - Amgen; ARIAD; Astellas Pharma; AstraZeneca; Boehringer Ingelheim; Calithera Biosciences; Euclises; Exelixis; Genentech; Guardant Health; Loxo; Precision Health Economics; Seagen; Takeda; Tesaro
Research Funding - Abbvie (Inst); ACEA Biosciences (Inst); Adaptimmune (Inst); ARIAD (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Guardant Health (Inst); Janssen Oncology (Inst); Loxo (Inst); Molecular Partners (Inst); Pfizer (Inst); Seagen (Inst); Xcovery (Inst); Zeno Pharmaceuticals (Inst)
 
Ebenezer A. Kio
Stock and Other Ownership Interests - Eisai; GlaxoSmithKline; Lilly
Consulting or Advisory Role - Ipsen; Novartis
Research Funding - Abbvie (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Ipsen; Novartis
 
Robert M. Langdon
Research Funding - Nebraska Cancer Specialists; Nebraska Methodist Hospital
 
Bamidele Adesunloye
Research Funding - Pfizer (Inst)
 
Ryan D. Gentzler
Honoraria - Rockpointe CME; Targeted Oncology
Consulting or Advisory Role - AstraZeneca; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Helsinn Therapeutics (Inst); Jounce Therapeutics (Inst); Merck (Inst); Pfizer (Inst); Takeda (Inst)
 
Nasser H. Hanna
Honoraria - UpToDate
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Merck KGaA (Inst)
Other Relationship - BeyondSpring Pharmaceuticals; BeyondSpring Pharmaceuticals
 
Greg Andrew Durm
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Merck (Inst)